NCT00449722View on ClinicalTrials.gov

OD vs. TID Dosing With Mesalazine Granules in Active Ulcerative Colitis

PHASE3CompletedINTERVENTIONAL
Enrollment

380

Participants

Timeline

Start Date

July 31, 2005

Study Completion Date

June 30, 2006

Conditions
Ulcerative Colitis
Interventions
DRUG

mesalazine

Trial Locations (1)

51103

Evangelisches Krankenhaus Kalk, Cologne

Sponsors
All Listed Sponsors
lead

Dr. Falk Pharma GmbH

INDUSTRY